Medtronic, Stryker, Boston Scientific, Intuitive Surgical, Abbott Labs. Switching costs + regulatory + brand moats compound in surgical instruments + implantable devices - the original 'razor-blade' healthcare model.
Industry leader
IRadimed Corporation IRMD
Buffett-Fit: 68/100
Medical devices compound through surgeon training + hospital purchasing relationships + FDA-approved product cycles. Once a surgeon is trained on a specific implant or surgical robot, switching costs are real - retraining, recertification, and surgeon preference all favour the incumbent. Look for ROIC above 15% + gross margins above 60%.
Sorted by composite quality score - ROIC, margin stability, balance-sheet strength, growth quality. Click any ticker for the full Buffett verdict.
See all industries + sector-level statistics + framework filters.
Educational framework analysis only. Not investment advice, not a recommendation, not personalized to your situation. Always do your own research.